[Role of adrenergic receptors in the regulation of the metabolism of macroenergetic cardiac phosphates. I. Effect of alpha-and beta-adrenergic agents].
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D001012:Aorta, Abdominal / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D004837:Epinephrine / Q000494:pharmacology; D004878:Ergotamine / Q000494:pharmacology; D006352:Heart Ventricles / Q000032:analysis; D008297:Male; D009206:Myocardium / Q000378:metabolism*; D010710:Phosphates / Q000378:metabolism*; D010725:Phosphocreatine / Q000378:metabolism*; D051381:Rats; D013565:Sympatholytics / Q000494:pharmacology*
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D010710:Phosphates; D013565:Sympatholytics; D010725:Phosphocreatine; D004878:Ergotamine; D004837:Epinephrine
Rola receptora adrenergicznego w regulacji metabolizmu makroenergetycznych fosforanów serca. I. Wpływ środków alfa i beta-adrenolitycznych.